Boosting ER-mitochondria calcium transfer to treat Wolfram syndrome
Wolfram syndrome is a rare genetic disorder characterized by endocrine dysfunction and progressive neurodegeneration. By targeting intracellular calcium dysregulations, a sigma-1 receptor agonist rescued neurological deficits in preclinical models of Wolfram syndrome.
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 March 2022
|
| In: |
Cell calcium
Year: 2022, Jahrgang: 104, Pages: 1-3 |
| ISSN: | 1532-1991 |
| DOI: | 10.1016/j.ceca.2022.102572 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ceca.2022.102572 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0143416022000471 |
| Verfasserangaben: | Tom T. Fischer, Lien D. Nguyen, Barbara E. Ehrlich |
| Zusammenfassung: | Wolfram syndrome is a rare genetic disorder characterized by endocrine dysfunction and progressive neurodegeneration. By targeting intracellular calcium dysregulations, a sigma-1 receptor agonist rescued neurological deficits in preclinical models of Wolfram syndrome. |
|---|---|
| Beschreibung: | Gesehen am 19.07.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1532-1991 |
| DOI: | 10.1016/j.ceca.2022.102572 |